Balchem Corp banner

Balchem Corp
F:BL9B

Watchlist Manager
Balchem Corp Logo
Balchem Corp
F:BL9B
Watchlist
Price: 131.7 EUR -1.2% Market Closed
Market Cap: €4.3B

Balchem Corp
Investor Relations

Balchem makes specialty ingredients and ingredient systems that help other companies improve food, nutrition, and industrial products. Its main business is supplying nutrients, minerals, choline-based ingredients, and protected delivery systems that keep sensitive ingredients stable and easier to use. The company sells these products to food makers, nutrition brands, animal feed producers, and some industrial customers. In human nutrition, Balchem supplies ingredients used in dietary supplements, foods, beverages, and medical nutrition. In animal nutrition, it sells feed additives that support livestock health and performance. It also serves industrial markets with specialty gas and moisture-control products used in packaging and manufacturing. Balchem usually earns money by selling these ingredients and formulations to business customers that need a reliable supply and consistent product performance. What makes Balchem different is that it sits in the middle of the ingredient chain rather than selling finished consumer brands. Its value comes from chemistry, formulation know-how, and products that solve practical problems like masking taste, protecting nutrients, or improving handling in production. That makes it a behind-the-scenes supplier that can be embedded in many everyday products without being visible to end consumers.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Apr 30, 2026
AI Summary
Q1 2026

Record quarter: Balchem reported record first-quarter revenue of $271 million, with record adjusted EBITDA of $74 million and adjusted EPS of $1.33.

Broad strength: All three segments grew sales year over year, with management saying demand remained healthy across most end markets.

Margins up: Gross margin expanded to 37.3%, helped by mix, manufacturing efficiency and price discipline, though input-cost inflation is starting to build.

Outlook steady: Management expects continued year-over-year growth, but warned of modest margin compression as pricing catches up with inflation, especially in Animal Nutrition & Health.

Brand push: Balchem highlighted new VitaCholine research and said it will invest more in science and marketing to expand the brand beyond prenatal nutrition into adult cognitive health.

Tax and costs: The company kept 23% as its planning tax rate, though it expects Q2 to run higher before easing in the back half of the year.

Key Financials
Revenue
$271 million
Earnings from operations
$56 million
Net income
$40 million
Earnings per share
$1.25
Adjusted EBITDA
$74 million
Adjusted earnings from operations
$61 million
Adjusted net earnings
$43 million
Adjusted EPS
$1.33
Gross margin
37.3%
Gross margin dollars
$101 million
Operating expenses
$45 million
Net interest expense
$2 million
Net debt
$96 million
Leverage ratio
0.3
Effective tax rate
23.3%
Cash from operations
$40 million
Free cash flow
$34 million
Cash on hand
$73 million
Human Nutrition & Health sales
$172 million
Human Nutrition & Health earnings from operations
$40 million
Animal Nutrition & Health sales
$62 million
Animal Nutrition & Health earnings from operations
$6 million
Specialty Products sales
$35 million
Specialty Products earnings from operations
$12 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Theodore L. Harris
Chairman, CEO & President
No Bio Available
Mr. Martin Luther Reid
Senior VP & Chief Supply Chain Officer
No Bio Available
Mr. Frederic Boned
Senior VP and GM of Human Nutrition & Health
No Bio Available
Mr. William A. Backus CPA
VP & Chief Accounting Officer
No Bio Available
Mr. Michael R. Sestrick Ph.D.
Senior VP & CTO
No Bio Available
Mr. Jonathan H. Griffin
Senior Vice President of Corporate Development
No Bio Available
Mr. M. Brent Tignor
Senior VP & Chief Human Resources Officer
No Bio Available
Mr. Job L. van Gunsteren
Senior VP & GM of Specialty Products
No Bio Available

Contacts

Address
NEW YORK
New Hampton
52 Sunrise Park Rd
Contacts
+18453265600.0
www.balchem.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett